CG Oncology, Inc. Common stock

10-Year Study

CGON.US · Healthcare · US · Common Stock

Executive Summary: CG Oncology, Inc. Common stock has compounded at 29.3% annually over the last 10 years, with a maximum drawdown of 45.2% and an annualized volatility of 161.1%.

1Y CAGR
+182.2%
3Y CAGR
+29.3%
5Y CAGR
+29.3%
10Y CAGR
+29.3%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
45.2%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.78
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.84
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
48.8%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +59.8%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · 44.8%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
100%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202625.413.015.1-2.0————————59.8%
20254.8-14.0-5.310.0-4.91.52.70.550.27.43.6-7.444.8%
2024—20.0-1.8-8.5-18.9-3.15.610.62.3-5.8-2.2-17.5-23.0%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 161.1%. The dominant macroeconomic risk driver is HYG.US, accounting for 18.4% of variance. Idiosyncratic stock-specific factors contribute 3.7%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-01-0110000
2024-02-0111999.463231347288
2024-03-0111782.071926999464
2024-04-0110786.366076221148
2024-05-018743.961352657005
2024-06-018472.893183038112
2024-07-018950.617283950618
2024-08-019898.013955984972
2024-09-0110126.14063338701
2024-10-019535.695115405262
2024-11-019326.355340848095
2024-12-017697.262479871177
2025-01-018070.3166935050995
2025-02-016940.418679549114
2025-03-016572.732152442298
2025-04-017230.273752012883
2025-05-016876.0064412238335
2025-06-016977.992485238862
2025-07-017163.177670424048
2025-08-017198.067632850242
2025-09-0110810.52066559313
2025-10-0111612.989801395599
2025-11-0112034.353193773486
2025-12-0111143.317230273753
2026-01-0113969.404186795491
2026-02-0115780.998389694041
2026-03-0118164.25120772947
2026-04-0117804.616210413315
Annual Return Matrix
YearAnnual Return
20250.4476987447698746
20260.5977842003853564
Total Factor Risk
1.6109140008506986
VTI.US Exposure
0.08818427479975278
VEA.US Exposure
0.033085718344022935
VWO.US Exposure
0.020335558204784828
QQQ.US Exposure
0.007257920773946413
VTV.US Exposure
0.07013606624899535
IJR.US Exposure
0.04999758991610678
QUAL.US Exposure
0.07399563835602863
SHV.US Exposure
0.13454270521580694
TLT.US Exposure
0.050248434920606495
LQD.US Exposure
0.05889051110051403
HYG.US Exposure
0.18426232512839408
GLD.US Exposure
0.00010829385924722958
USO.US Exposure
0.01041642127632855
VNQ.US Exposure
-0.0005629844931392884
BTC-USD.CC Exposure
-0.0017981645402932052
CPER.US Exposure
0.004636746684951192
VIX.INDX Exposure
0.007420500745098908
UUP.US Exposure
0.06120566784703306
TIP.US Exposure
0.11107405353026921
Idiosyncratic Exposure
0.036562722081545235
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
161.1%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$5.7B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+7.9%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+52.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
5.0% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.70
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is CG Oncology, Inc. Common stock a high-risk investment?

CG Oncology, Inc. Common stock (CGON.US) has an annualized volatility of 161.1% and experienced a maximum drawdown of 45.2% over the last 10 years. Its primary macro risk driver is HYG.US.

What is the 10-year return of CGON.US?

Over the past 10 years, CGON.US has generated a Compound Annual Growth Rate (CAGR) of 29.3%. It has had a positive return in 100% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on CG Oncology, Inc. Common stock

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest